COMPARATIVE STUDY OF ANTIBIOTICS FOR THEIR ANTIMICROBIAL SUSCEPTIBILITY IN CLINICAL ISOLATES
AbstractObjective: Antibiotics resistance patterns for many bacteria have changed significantly; causing poor clinical outcomes. The objective of the study was to measure the susceptibility of different antibiotics against specific clinical isolates for surveillance purpose. Method: Kirby-Bauer disc diffusion method was used to evaluate the susceptibility pattern of four antibiotics (commercially available disc) i.e., Amoxicillin, Cefixime, Ciprofloxacin and Levofloxacin against different clinical isolates collected from various hospitals. The clinical isolates selected for the proposed study were of Staphylococcus aureus, Streptococcus Pneumoniae, Klebsiella Pneumoniae, Pseudomonas aeruginosa, Salmonella typhi and Escherichia coli. This collection of antibiotics and isolates were due to common pathogens and highly prescribed Oral antibiotics. Result: Results show that amoxicillin and cefixime are highly resistant; cefixime is sensitive against Salmonella typhi and Streptococcus Pneumoniae but 50 % resistant to the microbes. In quinolones, ciprofloxacin and levofloxacin have good sensitivity; Levofloxacin is a better choice against aforementioned pathogens. Conclusion: It was concluded that bacterial resistance rates vary among species and also from hospital to hospital. Irrational uses of antibiotics cause the change in the resistances that argue strongly for more susceptibility testing of organism. Moreover these situations compel the manufacturer and health care professionals to work over it and guide prescriber for proper selection of antibiotics.
Article Information
14
630-635
414KB
1590
English
Ijpsr
Farheen Zaheer , Shahnaz Usman *, Sakina Fatima and Muhhammad Mohtasheem Ul Hasan
Department of pharmaceutics Rak College of pharmaceutical sciences, RAKMHSU, Ras Al Khaimah, UAE. Postal code: 11172
shahnaz.usman@rakmhsu.ac.ae
03 July, 2014
03 September, 2014
19 January, 2015
http://dx.doi.org/10.13040/IJPSR.0975-8232.6(2).630-35
01 February, 2015